 Harold Fisher Dvorak, M.D.
| Title | Mallinckrodt Distinguished Professor of Pathology |
|---|
| Institution | Beth Israel Deaconess Medical Center |
|---|
| Department | Pathology |
|---|
| Address | Beth Israel Deaconess Med Ctr
Pathology, ES-102B
330 Brookline Ave
Boston MA 02215
|
|---|
| Phone | 617/667-4343 |
|---|
| Fax | 617/667-2913 |
|---|
|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Qin L, Zhao D, Xu J, Ren X, Terwilliger EF, Parangi S, Lawler J, Dvorak HF, Zeng H. The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. Blood. 2013 Mar 14; 121(11):2154-64.
-
Nagy JA, Dvorak HF. Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets. Clin Exp Metastasis. 2012 Oct; 29(7):657-62.
-
Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cß3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73.
-
Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 2012 Apr 15; 72(8):1909-14.
-
Nagy JA, Dvorak AM, Dvorak HF. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med. 2012 Feb; 2(2):a006544.
-
Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Forty-year journey of angiogenesis translational research. Sci Transl Med. 2011 Dec 21; 3(114):114rv3.
-
Sitohy B, Nagy JA, Jaminet SC, Dvorak HF. Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy. Cancer Res. 2011 Nov 15; 71(22):7021-8.
-
Zhao D, Qin L, Bourbon PM, James L, Dvorak HF, Zeng H. Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions. Proc Natl Acad Sci U S A. 2011 Jul 19; 108(29):12066-71.
-
Zukauskas A, Merley A, Li D, Ang LH, Sciuto TE, Salman S, Dvorak AM, Dvorak HF, Jaminet SC. TM4SF1: a tetraspanin-like protein necessary for nanopodia formation and endothelial cell migration. Angiogenesis. 2011 Sep; 14(3):345-54.
-
Dvorak HF, Weaver VM, Tlsty TD, Bergers G. Tumor microenvironment and progression. J Surg Oncol. 2011 May 1; 103(6):468-74.
-
Fu Y, Nagy JA, Brown LF, Shih SC, Johnson PY, Chan CK, Dvorak HF, Wight TN. Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis. J Histochem Cytochem. 2011 May; 59(5):463-73.
-
Wada Y, Li D, Merley A, Zukauskas A, Aird WC, Dvorak HF, Shih SC. A multi-gene transcriptional profiling approach to the discovery of cell signature markers. Cytotechnology. 2011 Jan; 63(1):25-33.
-
Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin Thromb Hemost. 2010 Apr; 36(3):321-31.
-
Dvorak HF. Vascular permeability to plasma, plasma proteins, and cells: an update. Curr Opin Hematol. 2010 May; 17(3):225-9.
-
Dvorak HF. My friend Marty. J Cutan Pathol. 2010 Apr; 37 Suppl 1:6-7.
-
Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol. 2009 Oct; 175(4):1768-76.
-
Zhang X, Kazerounian S, Duquette M, Perruzzi C, Nagy JA, Dvorak HF, Parangi S, Lawler J. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J. 2009 Oct; 23(10):3368-76.
-
Xue Q, Nagy JA, Manseau EJ, Phung TL, Dvorak HF, Benjamin LE. Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler Thromb Vasc Biol. 2009 Aug; 29(8):1172-8.
-
Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, Kalluri R, Dvorak HF. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res. 2009 May 15; 69(10):4537-44.
-
Shih SC, Zukauskas A, Li D, Liu G, Ang LH, Nagy JA, Brown LF, Dvorak HF. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res. 2009 Apr 15; 69(8):3272-7.
-
Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer. 2009 Mar 24; 100(6):865-9.
-
Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008; 11(2):109-19.
-
Nagy JA, Shih SC, Wong WH, Dvorak AM, Dvorak HF. Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay. Methods Enzymol. 2008; 444:43-64.
-
Carman CV, Sage PT, Sciuto TE, de la Fuente MA, Geha RS, Ochs HD, Dvorak HF, Dvorak AM, Springer TA. Transcellular diapedesis is initiated by invasive podosomes. Immunity. 2007 Jun; 26(6):784-97.
-
Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, Nagy JA, Dvorak HF, Ylä-Herttuala S, Shibuya M, Alitalo K. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med. 2007 Jun 11; 204(6):1431-40.
-
Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007; 2:251-75.
-
Qin L, Zhao D, Liu X, Nagy JA, Hoang MV, Brown LF, Dvorak HF, Zeng H. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol Cancer Res. 2006 Nov; 4(11):811-20.
-
Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I, Nagy JA, Lin MI, Walsh K, Dvorak AM, Briscoe DM, Neeman M, Sessa WC, Dvorak HF, Benjamin LE. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell. 2006 Aug; 10(2):159-70.
-
Nagy JA, Feng D, Vasile E, Wong WH, Shih SC, Dvorak AM, Dvorak HF. Permeability properties of tumor surrogate blood vessels induced by VEGF-A. Lab Invest. 2006 Aug; 86(8):767-80.
-
Zeng H, Qin L, Zhao D, Tan X, Manseau EJ, Van Hoang M, Senger DR, Brown LF, Nagy JA, Dvorak HF. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med. 2006 Mar 20; 203(3):719-29.
-
Dvorak HF. Discovery of vascular permeability factor (VPF). Exp Cell Res. 2006 Mar 10; 312(5):522-6.
-
Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost. 2005 Aug; 3(8):1835-42.
-
Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell. 2005 Mar; 7(3):251-61.
-
Stiver SI, Tan X, Brown LF, Hedley-Whyte ET, Dvorak HF. VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol. 2004 Aug; 63(8):841-55.
-
Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem. 2004 Jan; 52(1):87-101.
-
Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G, Detmar M. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003 Jul 15; 22(14):3546-56.
-
Nagy JA, Dvorak AM, Dvorak HF. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003 Jul; 13(5):169-75.
-
Dvorak HF. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol. 2003 Jun; 162(6):1747-57.
-
Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 2002 Dec 2; 196(11):1497-506.
-
McCarty JH, Monahan-Earley RA, Brown LF, Keller M, Gerhardt H, Rubin K, Shani M, Dvorak HF, Wolburg H, Bader BL, Dvorak AM, Hynes RO. Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking alphav integrins. Mol Cell Biol. 2002 Nov; 22(21):7667-77.
-
Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002 Nov 1; 20(21):4368-80.
-
Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002 Aug; 8(8):831-40.
-
Feng D, Nagy JA, Dvorak HF, Dvorak AM. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc Res Tech. 2002 Jun 1; 57(5):289-326.
-
Sundberg C, Kowanetz M, Brown LF, Detmar M, Dvorak HF. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest. 2002 Apr; 82(4):387-401.
-
Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Manseau EJ, Dvorak AM, Dvorak HF. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. Cold Spring Harb Symp Quant Biol. 2002; 67:227-37.
-
Epstein SE, Kornowski R, Fuchs S, Dvorak HF. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation. 2001 Jul 3; 104(1):115-9.
-
Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 2001 Jul 20; 276(29):26969-79.
-
Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001 May; 7(5):569-74.
-
Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol. 2001 Mar; 158(3):1145-60.
-
Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001 Feb; 15(2):458-66.
-
Mentzel T, Brown LF, Dvorak HF, Kuhnen C, Stiller KJ, Katenkamp D, Fletcher CD. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma. Virchows Arch. 2001 Jan; 438(1):13-22.
-
Pal S, Iruela-Arispe ML, Harvey VS, Zeng H, Nagy JA, Dvorak HF, Mukhopadhyay D. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Microvasc Res. 2000 Sep; 60(2):112-20.
-
Brown LF, Dezube BJ, Tognazzi K, Dvorak HF, Yancopoulos GD. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol. 2000 Jun; 156(6):2179-83.
-
Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem. 2000 Apr; 48(4):545-56.
-
Dvorak HF. VPF/VEGF and the angiogenic response. Semin Perinatol. 2000 Feb; 24(1):75-8.
-
Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 2000 Jan; 80(1):99-115.
-
Feng D, Nagy JA, Dvorak AM, Dvorak HF. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res. 2000 Jan; 59(1):24-37.
-
Fu Y, Comella N, Tognazzi K, Brown LF, Dvorak HF, Kocher O. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene. 1999 Nov 15; 240(1):157-63.
-
Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res. 1999 May; 5(5):1041-56.
-
Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation. 1999 Mar; 6(1):23-44.
-
Vasile E. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J Histochem Cytochem. 1999 Feb; 47(2):159-67.
-
Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999; 237:97-132.
-
Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998 Sep 21; 188(6):1135-45.
-
Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Platelets exit venules by a transcellular pathway at sites of F-met peptide-induced acute inflammation in guinea pigs. Int Arch Allergy Immunol. 1998 Jul; 116(3):188-95.
-
Brown LF, Guidi AJ, Tognazzi K, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia. Insights from in situ hybridization studies. J Histochem Cytochem. 1998 May; 46(5):569-75.
-
Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med. 1998 Mar 16; 187(6):903-15.
-
Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res. 1998 Mar 15; 58(6):1278-84.
-
Neulen J, Raczek S, Pogorzelski M, Grunwald K, Yeo TK, Dvorak HF, Weich HA, Breckwoldt M. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod. 1998 Mar; 4(3):203-6.
-
Denhart BC, Guidi AJ, Tognazzi K, Dvorak HF, Brown LF. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest. 1997 Dec; 77(6):659-64.
-
Guidi AJ, Schnitt SJ, Fischer L, Tognazzi K, Harris JR, Dvorak HF, Brown LF. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 1997 Nov 15; 80(10):1945-53.
-
Feng D, Nagy JA, Hipp J, Pyne K, Dvorak HF, Dvorak AM. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores. J Physiol. 1997 Nov 1; 504 ( Pt 3):747-61.
-
Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J Biol Chem. 1997 Oct 31; 272(44):27509-12.
-
Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost. 1997 Jul; 78(1):672-7.
-
Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF. Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest. 1997 Jul; 77(1):103-8.
-
Watanabe Y, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp Cell Res. 1997 Jun 15; 233(2):340-9.
-
Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene. 1997 May 1; 14(17):2025-32.
-
Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol. 1997 Mar; 108(3):263-8.
-
Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J Histochem Cytochem. 1997 Jan; 45(1):21-33.
-
Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997; 79:233-69.
-
Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor. Eur J Cancer. 1996 Dec; 32A(14):2467-73.
-
Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996 Oct; 114(10):1210-7.
-
Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 1996 Aug 1; 78(3):454-60.
-
Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest. 1996 Jun; 74(6):1105-15.
-
Yeo TK, Nagy JA, Yeo KT, Dvorak HF, Toole BP. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol. 1996 Jun; 148(6):1733-40.
-
Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med. 1996 May 1; 183(5):1981-6.
-
Brown LF, Tognazzi K, Dvorak HF, Harrist TJ. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol. 1996 Apr; 148(4):1065-74.
-
Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol. 1996 Jan; 59(1):100-15.
-
Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 1996 Jan 1; 56(1):172-81.
-
Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst. 1995 Aug 16; 87(16):1237-45.
-
Brown LF, Yeo KT, Berse B, Morgentaler A, Dvorak HF, Rosen S. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol. 1995 Aug; 154(2 Pt 1):576-9.
-
Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol. 1995 Jul; 105(1):44-50.
-
Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995 May; 146(5):1029-39.
-
Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995 May-Jun; 107(1-3):233-5.
-
Brown LF, Harrist TJ, Yeo KT, Ståhle-Bäckdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol. 1995 May; 104(5):744-9.
-
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem. 1995 Apr; 43(4):381-9.
-
Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol. 1995 Mar 15; 154(6):2801-7.
-
Friedman L, Dvorak HF. The negative tuberculin test: tuberculin, HIV, and anergy panels. Am J Respir Crit Care Med. 1995 Feb; 151(2 Pt 1):580.
-
Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res. 1995 Jan 15; 55(2):376-85.
-
Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res. 1995 Jan 15; 55(2):360-8.
-
Nagy JA, Meyers MS, Masse EM, Herzberg KT, Dvorak HF. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res. 1995 Jan 15; 55(2):369-75.
-
Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 1995 Jan; 26(1):86-91.
-
Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol. 1995 Jan; 146(1):157-65.
-
Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR. Osteopontin expression and distribution in human carcinomas. Am J Pathol. 1994 Sep; 145(3):610-23.
-
Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994 Sep 1; 180(3):1141-6.
-
Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994 Sep; 145(3):574-84.
-
Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med. 1994 Jul 1; 180(1):341-6.
-
Lin K, Nagy JA, Xu H, Shockley TR, Yarmush ML, Dvorak HF. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res. 1994 Apr 15; 54(8):2269-77.
-
Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells. J Histochem Cytochem. 1994 Mar; 42(3):351-61.
-
Senger DR, Brown LF, Claffey KP, Dvorak HF. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis. 1994-1995; 14(1-6):385-94.
-
Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol. 1993 Nov; 143(5):1255-62.
-
Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 1993 Oct 1; 53(19):4727-35.
-
Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993 Sep; 12(3-4):303-24.
-
Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res. 1993 Jun 15; 53(12):2912-8.
-
Nagy JA, Herzberg KT, Dvorak JM, Dvorak HF. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res. 1993 Jun 1; 53(11):2631-43.
-
Schnitt SJ, Stillman IE, Owings DV, Kishimoto C, Dvorak HF, Abelmann WH. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy. Circ Res. 1993 Apr; 72(4):914-20.
-
Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van de Water L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol. 1993 Mar; 142(3):793-801.
-
Sioussat TM, Dvorak HF, Brock TA, Senger DR. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys. 1993 Feb 15; 301(1):15-20.
-
Dvorak AM, Weller PF, Harvey VS, Morgan ES, Dvorak HF. Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int Arch Allergy Immunol. 1993; 101(2):136-42.
-
Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993 Jan; 142(1):273-83.
-
Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo KT, Yeo TK, Dvorak AM, van de Water L, Sioussat TM, Senger DR. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci. 1992 Dec 4; 667:101-11.
-
Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 1992 Dec; 42(6):1457-61.
-
Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest. 1992 Nov; 67(5):596-607.
-
Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 1992 Nov 1; 176(5):1375-9.
-
Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell. 1992 Oct; 3(10):1169-80.
-
Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992 Feb; 3(2):211-20.
-
Shockley TR, Lin K, Nagy JA, Tompkins RG, Yarmush ML, Dvorak HF. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res. 1992 Jan 15; 52(2):367-76.
-
Shockley TR, Lin K, Sung C, Nagy JA, Tompkins RG, Dedrick RL, Dvorak HF, Yarmush ML. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Cancer Res. 1992 Jan 15; 52(2):357-66.
-
Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Cancer Res. 1992 Jan 15; 52(2):377-84.
-
Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med. 1991 Nov 1; 174(5):1275-8.
-
Yeo TK, Senger DR, Dvorak HF, Freter L, Yeo KT. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun. 1991 Sep 30; 179(3):1568-75.
-
Yeo TK, Brown L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol. 1991 Jun; 138(6):1437-50.
-
Dvorak HF, Nagy JA, Dvorak AM. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells. 1991 Mar; 3(3):77-85.
-
Brock TA, Dvorak HF, Senger DR. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol. 1991 Jan; 138(1):213-21.
-
Shockley TR, Lin K, Nagy JA, Tompkins RG, Dvorak HF, Yarmush ML. Penetration of tumor tissue by antibodies and other immunoproteins. Ann N Y Acad Sci. 1991; 618:367-82.
-
Weller PF, Monahan-Earley RA, Dvorak HF, Dvorak AM. Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am J Pathol. 1991 Jan; 138(1):141-8.
-
Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990 Mar 15; 50(6):1774-8.
-
Fossel ET, Dvorak HF, Carr JM, McDonagh J. Alteration of aliphatic lipid proton NMR linewidths by malignant tumors in guinea pigs. Eur J Cancer. 1990 Jan; 26(1):29-32.
-
Dvorak HF. Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy. Prog Clin Biol Res. 1990; 354A:317-30.
-
Brown LF, Dvorak AM, Dvorak HF. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am Rev Respir Dis. 1989 Oct; 140(4):1104-7.
-
Nagy JA, Herzberg KT, Masse EM, Zientara GP, Dvorak HF. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res. 1989 Oct 1; 49(19):5448-58.
-
Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol. 1989 Aug; 109(2):903-14.
-
Dvorak HF, Gresser I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst. 1989 Apr 5; 81(7):497-502.
-
Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, Dvorak HF. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta. 1989 Feb; 948(3):305-26.
-
Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol. 1988 Oct; 133(1):95-109.
-
Lanir N, Ciano PS, Van de Water L, McDonagh J, Dvorak AM, Dvorak HF. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol. 1988 Apr 1; 140(7):2340-9.
-
Brown LF, Asch B, Harvey VS, Buchinski B, Dvorak HF. Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. Cancer Res. 1988 Apr 1; 48(7):1920-5.
-
Brown LF, Van de Water L, Harvey VS, Dvorak HF. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol. 1988 Mar; 130(3):455-65.
-
Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest. 1987 Dec; 57(6):673-86.
-
Monahan-Earley RA, Isomura T, Garcia RI, Galli SJ, Dvorak HF, Dvorak AM. Nonspecific esterase activity expressed in Weibel-Palade bodies of cloned guinea pig aortic endothelial cells. J Histochem Cytochem. 1987 May; 35(5):531-9.
-
Brown LF, Chester JF, Malt RA, Dvorak HF. Fibrin deposition in autochthonous Syrian hamster pancreatic adenocarcinomas induced by the chemical carcinogen N-nitroso-bis(2-oxopropyl)amine. J Natl Cancer Inst. 1987 May; 78(5):979-86.
-
Dvorak HF. Thrombosis and cancer. Hum Pathol. 1987 Mar; 18(3):275-84.
-
Dvorak AM, Monahan-Earley RA, Dvorak HF, Galli SJ. Ultrastructural cytochemical and autoradiographic demonstration of nonspecific esterase(s) in guinea pig basophils. J Histochem Cytochem. 1987 Mar; 35(3):351-60.
-
Locke SE, Ransil BJ, Covino NA, Toczydlowski J, Lohse CM, Dvorak HF, Arndt KA, Frankel FH. Failure of hypnotic suggestion to alter immune response to delayed-type hypersensitivity antigens. Ann N Y Acad Sci. 1987; 496:745-9.
-
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986 Dec 25; 315(26):1650-9.
-
Isomura T, Dvorak AM, Garcia RI, Dvorak HF, Galli SJ. Inbred guinea pig aortic endothelial cell clones. Model for studying the vascular endothelium under totally isologous conditions. Lab Invest. 1986 Dec; 55(6):703-16.
-
Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986 Nov; 46(11):5629-32.
-
Faix JD, Wiberg L, Dvorak HF. Antibody enhances lymphocyte proliferation in guinea pigs immunized to express cutaneous basophil hypersensitivity. Cell Immunol. 1986 May; 99(2):354-63.
-
Mekori YA, Dvorak HF, Galli SJ. 125I-fibrin deposition in contact sensitivity reactions in the mouse. Sensitivity of the assay for quantitating reactions after active or passive sensitization. J Immunol. 1986 Mar 15; 136(6):2018-25.
-
Dvorak HF, Galli SJ, Dvorak AM. Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol. 1986 Feb; 17(2):122-37.
-
Ciano PS, Colvin RB, Dvorak AM, McDonagh J, Dvorak HF. Macrophage migration in fibrin gel matrices. Lab Invest. 1986 Jan; 54(1):62-70.
-
VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res. 1985 Nov; 45(11 Pt 1):5521-5.
-
Carr JM, Dvorak AM, Dvorak HF. Circulating membrane vesicles in leukemic blood. Cancer Res. 1985 Nov; 45(11 Pt 2):5944-51.
-
Hammel I, Dvorak AM, Peters SP, Schulman ES, Dvorak HF, Lichtenstein LM, Galli SJ. Differences in the volume distributions of human lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms. J Cell Biol. 1985 May; 100(5):1488-92.
-
Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J. Regulation of extravascular coagulation by microvascular permeability. Science. 1985 Mar 1; 227(4690):1059-61.
-
Dvorak AM, Dvorak HF, Galli SJ. Surface membrane traffic in guinea pig basophils exposed to cationic ferritin. Int Arch Allergy Appl Immunol. 1985; 77(1-2):267-73.
-
deShazo RD, Griffing C, Kwan TH, Banks WA, Dvorak HF. Dermal hypersensitivity reactions to imported fire ants. J Allergy Clin Immunol. 1984 Dec; 74(6):841-7.
-
Dvorak HF, Form DM, Manseau EJ, Smith BD. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J Natl Cancer Inst. 1984 Nov; 73(5):1195-205.
-
Form DM, VanDeWater L, Dvorak HF, Smith BD. Pathogenesis of tumor desmoplasia. II. Collagens synthesized by line 1 and line 10 guinea pig carcinoma cells and by syngeneic fibroblasts in vitro. J Natl Cancer Inst. 1984 Nov; 73(5):1207-14.
-
Dvorak AM, Hammel I, Schulman ES, Peters SP, MacGlashan DW, Schleimer RP, Newball HH, Pyne K, Dvorak HF, Lichtenstein LM, et al. Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol. 1984 Nov; 99(5):1678-87.
-
Clark RA, Horsburgh CR, Hoffman AA, Dvorak HF, Mosesson MW, Colvin RB. Fibronectin deposition in delayed-type hypersensitivity. Reactions of normals and a patient with afibrinogenemia. J Clin Invest. 1984 Sep; 74(3):1011-6.
-
Dvorak HF, Harvey VS, McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res. 1984 Aug; 44(8):3348-54.
-
Galli SJ, Dvorak AM, Dvorak HF. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy. 1984; 34:1-141.
-
Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW, Pyne K, Harvey VS, Galli SJ, Lichtenstein LM. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol. 1983 Dec; 131(6):2965-76.
-
Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho AC. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res. 1983 Sep; 43(9):4434-42.
-
Dvorak AM, Dvorak HF, Galli SJ. Ultrastructural criteria for identification of mast cells and basophils in humans, guinea pigs, and mice. Am Rev Respir Dis. 1983 Aug; 128(2 Pt 2):S49-52.
-
DeShazo RD, Levinson AI, Dvorak HF. The late phase skin reaction: paradigm or epiphenomena? Ann Allergy. 1983 Aug; 51(2 Pt 1):166-72.
-
Clark RA, Winn HJ, Dvorak HF, Colvin RB. Fibronectin beneath reepithelializing epidermis in vivo: sources and significance. J Invest Dermatol. 1983 Jun; 80(1 Suppl):26s-30s.
-
Clark RA, Winn HJ, Dvorak HF, Colvin RB. Fibronectin beneath reepithelializing epidermis in vivo: sources and significance. J Invest Dermatol. 1983 Jun; 80 Suppl:26s-30s.
-
Dvorak AM, Galli SJ, Schulman ES, Lichtenstein LM, Dvorak HF. Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release. Fed Proc. 1983 May 15; 42(8):2510-5.
-
Senger DR, Asch BB, Smith BD, Perruzzi CA, Dvorak HF. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature. 1983 Apr 21; 302(5910):714-5.
-
Orenstein NS, Buczynski A, Dvorak HF. Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture. Cancer Res. 1983 Apr; 43(4):1783-9.
-
Dvorak AM, Galli SJ, Marcum JA, Nabel G, der Simonian H, Goldin J, Monahan RA, Pyne K, Cantor H, Rosenberg RD, Dvorak HF. Cloned mouse cells with natural killer function and cloned suppressor T cells express ultrastructural and biochemical features not shared by cloned inducer T cells. J Exp Med. 1983 Mar 1; 157(3):843-61.
-
Kadish JL, Wenc KM, Dvorak HF. Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst. 1983 Mar; 70(3):551-7.
-
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983 Feb 25; 219(4587):983-5.
-
Galli SJ, Dvorak AM, Dvorak HF. Mouse mast cells and other granulated leukocyte clones. Ultrastructure of cloned mouse leukocytes. Monogr Allergy. 1983; 18:129-37.
-
Galli SJ, Dvorak AM, Marcum JA, Nabel G, Goldin JM, Rosenberg RD, Cantor H, Dvorak HF. Mouse mast cell clones: modulation of functional maturity in vitro. Monogr Allergy. 1983; 18:166-70.
-
Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev. 1983; 2(1):41-73.
-
Galli SJ, Dvorak AM, Marcum JA, Ishizaka T, Nabel G, Der Simonian H, Pyne K, Goldin JM, Rosenberg RD, Cantor H, Dvorak HF. Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol. 1982 Nov; 95(2 Pt 1):435-44.
-
Clark RA, DellaPelle P, Manseau E, Lanigan JM, Dvorak HF, Colvin RB. Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. J Invest Dermatol. 1982 Nov; 79(5):269-76.
-
Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol. 1982 Nov; 79(5):264-9.
-
Bhan AK, Mihm MC, Dvorak HF. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol. 1982 Oct; 129(4):1578-83.
-
Galli SJ, Bast RC, Bast BS, Isomura T, Zbar B, Rapp HJ, Dvorak HF. Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature. J Immunol. 1982 Aug; 129(2):890-9.
-
Galli SJ, Dvorak AM, Ishizaka T, Nabel G, Der Simonian H, Cantor H, Dvorak HF. A cloned cell with NK function resembles basophils by ultrastructure and expresses IgE receptors. Nature. 1982 Jul 15; 298(5871):288-90.
-
Harris NL, Dvorak AM, Smith J, Dvorak HF. Fibrin deposits in Hodgkin's disease. Am J Pathol. 1982 Jul; 108(1):119-29.
-
Dvorak AM, Nabel G, Pyne K, Cantor H, Dvorak HF, Galli SJ. Ultrastructural identification of the mouse basophil. Blood. 1982 Jun; 59(6):1279-85.
-
Dvorak AM, Galli SJ, Morgan E, Galli AS, Hammond ME, Dvorak HF. Anaphylactic degranulation of guinea pig basophilic leukocytes. II. Evidence for regranulation of mature basophils during recovery from degranulation in vitro. Lab Invest. 1982 May; 46(5):461-75.
-
deShazo RD, Boehm TM, Kumar D, Galloway JA, Dvorak HF. Dermal hypersensitivity reactions to insulin: correlations of three patterns to their histopathology. J Allergy Clin Immunol. 1982 Feb; 69(2):229-37.
-
Monahan RA, Dvorak HF, Dvorak AM. Ultrastructural localization of nonspecific esterase activity in guinea pig and human monocytes, macrophages, and lymphocytes. Blood. 1981 Dec; 58(6):1089-99.
-
Dvorak HF, Dickersin GR, Dvorak AM, Manseau EJ, Pyne K. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst. 1981 Aug; 67(2):335-45.
-
Dvorak AM, Osage JE, Dvorak HF, Galli SJ. Surface membrane alterations in guinea pig basophils undergoing anaphylactic degranulation. A scanning electron microscopic study. Lab Invest. 1981 Jul; 45(1):58-66.
-
Nabel G, Galli SJ, Dvorak AM, Dvorak HF, Cantor H. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature. 1981 May 28; 291(5813):332-4.
-
Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, Carvalho AC. Tumor shedding and coagulation. Science. 1981 May 22; 212(4497):923-4.
-
Galli SJ, Dvorak AM, Hammond ME, Morgan E, Galli AS, Dvorak HF. Guinea pig basophil morphology in vitro. I. Ultrastructure of uropod-bearing (motile) basophils and modulation of motile structures by serum and substrate effects. J Immunol. 1981 Mar; 126(3):1066-74.
-
Clark RA, Dvorak HF, Colvin RB. Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. J Immunol. 1981 Feb; 126(2):787-93.
-
Dvorak AM, Galli SJ, Morgan E, Galli AS, Hammond ME, Dvorak HF. Anaphylactic degranulation of guinea pig basophilic leukocytes. I. Fusion of granule membranes and cytoplasmic vesicles formation and resolution of degranulation sacs. Lab Invest. 1981 Feb; 44(2):174-91.
-
Dvorak AM, Galli SJ, Dvorak HF. A role for cytoplasmic vesicles in anaphylactic degranulation of guinea pig basophils. Int Arch Allergy Appl Immunol. 1981; 66 Suppl 1:234-8.
-
Orenstein NS, Galli SJ, Dvorak AM, Dvorak HF. Glycosaminoglycans and proteases of guinea pig basophilic leukocytes. Kroc Found Ser. 1981; 14:123-43.
-
Dvorak AM, Mihm MC, Osage JE, Dvorak HF. Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol. 1980 Nov; 75(5):388-93.
-
Dvorak AM, Newball HH, Dvorak HF, Lichtenstein LM. Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest. 1980 Aug; 43(2):126-39.
-
Dvorak HF, Mihm MC, Dvorak AM, Barnes BA, Galli SJ. The microvasculature is the critical target of the immune response in vascularized skin allograft rejection. J Invest Dermatol. 1980 May; 74(5):280-4.
-
Hammond ME, Goodwin J, Dvorak HF. Quantitative measurements of neutral red uptake and excretion by mammalian cells. J Reticuloendothel Soc. 1980 Mar; 27(3):337-46.
-
Dvorak AM, Hammond ME, Morgan ES, Dvorak HF. Ultrastructural studies of macrophages: in vitro removal of cell coat with macrophage inhibition factor (MIF)-containing lymphocyte culture supernatants; chloroform extraction, phospholipase digestion, and autoradiographic studies. J Reticuloendothel Soc. 1980 Feb; 27(2):119-42.
-
Dvorak AM, Hammond ME, Morgan E, Orenstein NS, Galli SJ, Dvorak HF. Evidence for a vesicular transport mechanism in guinea pig basophilic leukocytes. Lab Invest. 1980 Feb; 42(2):263-76.
-
Dvorak HF, Galli SJ, Dvorak AM. Expression of cell-mediated hypersensitivity in vivo--recent advances. Int Rev Exp Pathol. 1980; 21:119-94.
-
Dvorak AM, Dvorak HF. The basophil. Its morphology, biochemistry, motility, release reactions, recovery, and role in the inflammatory responses of IgE-mediated and cell-mediated origin. Arch Pathol Lab Med. 1979 Oct; 103(11):551-7.
-
Dvorak HF, Mihm MC, Dvorak AM, Barnes BA, Manseau EJ, Galli SJ. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979 Aug 1; 150(2):322-37.
-
Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst. 1979 Jun; 62(6):1459-72.
-
Colvin RB, Mosesson MW, Dvorak HF. Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest. 1979 Jun; 63(6):1302-6.
-
Dvorak AM, Galli SJ, Galli AS, Hammond ME, Churchill WH, Dvorak HF. Tumor-basophil interactions in vitro--a scanning and transmission electron microscopic study. J Immunol. 1979 Jun; 122(6):2447-57.
-
Dvorak AM, Roblin RO, Morgan ES, Dvorak HF. Ultrastructure of the cell coat of untransformed and simian virus 40-transformed fibroblasts. J Reticuloendothel Soc. 1979 Feb; 25(2):163-77.
-
deShazo RD, Levinson AI, Dvorak HF, Davis RW. The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol. 1979 Feb; 122(2):692-8.
-
Dvorak HF, Orenstein NS, Galli SJ, Dvorak AM. Plasminogen activator of guinea pig basophils. A protease probably localized to the cell surface. Monogr Allergy. 1979; 14:249-52.
-
Dvorak HF. Introduction--heterogeneity of the cellular immune response. Adv Exp Med Biol. 1979; 114:369-74.
-
Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J, Giovinco P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol. 1979 Jan; 122(1):166-74.
-
Orenstein NS, Dvorak HF, Blanchard MH, Young M. Nerve growth factor: a protease that can activate plasminogen. Proc Natl Acad Sci U S A. 1978 Nov; 75(11):5497-500.
-
Galli SJ, Colvin RB, Verderber E, Galli AS, Monahan R, Dvorak AM, Dvorak HF. Preparation of a rabbit anti-guinea pig basophil serum: in vitro and in vivo characterization. J Immunol. 1978 Sep; 121(3):1157-66.
-
Feder J, Kimes RC, Tolbert WR, Cleveland C, Hammond ME, Orenstein NS, Goodwin J, Dvorak HF. Plasminogen activator and MIF-like activities in Kirsten virus transformed mouse NIH culture fluids. Biochem Biophys Res Commun. 1978 Aug 14; 83(3):1164-70.
-
Orenstein NS, Galli SJ, Dvorak AM, Silbert JE, Dvorak HF. Sulfated glycosaminoglycans of guinea pig basophilic leukocytes. J Immunol. 1978 Aug; 121(2):586-92.
-
Hammond ME, Dvorak AM, Roblin RO, Morgan ES, Dvorak HF. Effect of E-amino caproic acid on macrohage cell coat and migration inhibtion. J Reticuloendothel Soc. 1978 Jul; 24(1):63-72.
-
Soter NA, Mihm MC, Dvorak HF, Austen KF. Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndrome. Clin Exp Immunol. 1978 Apr; 32(1):46-58.
-
Dvorak AM, Connell AB, Proppe K, Dvorak HF. Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation. J Immunol. 1978 Apr; 120(4):1240-8.
-
Dvorak HF, Orenstein NS, Rypysc J, Colvin RB, Dvorak AM. Plasminogen activator of guinea pig basophilic leukocytes: probable localization to the plasma membrane. J Immunol. 1978 Mar; 120(3):766-73.
-
Galli SJ, Colvin RB, Orenstein NS, Dvorak AM, Dvorak HF. Patients without basophils. Lancet. 1977 Aug 20; 2(8034):409.
-
Dvorak HF, Orenstein NS, Dvorak AM, Hammond ME, Roblin RO, Feder J, Schott CF, Goodwin J, Morgan E. Isolation of the cytoplasmic granules of guinea pig basophilic leukocytes: identification of esterase and protease activities. J Immunol. 1977 Jul; 119(1):38-46.
-
Dvorak HF, Hammond ME, Colvin RB, Manseau EJ, Goodwin J. Systemic expression of cutaneous basophil hypersensitivity. J Immunol. 1977 May; 118(5):1549-57.
-
McMaster PR, Owens JD, Dvorak HF, Weichbrod R, Asofsky R. Hapten-specific delayed hypersensitivity to epsilon-2,4-dinitrophenyl-L-lysine-Ficoll in guinea pigs immunized with 2,4-dinitrophenyl-keyhole limpet hemocyanin. J Exp Med. 1977 May 1; 145(5):1101-14.
-
Friedlaender MH, Dvorak HF. Morphology of delayed-type hypersensitivity reactions in the guinea pig cornea. J Immunol. 1977 May; 118(5):1558-63.
-
Roblin RO, Hammond ME, Bensky ND, Dvorak AM, Dvorak HF, Black PH. Generation of macrophage migration inhibitory activity by plasminogen activators. Proc Natl Acad Sci U S A. 1977 Apr; 74(4):1570-4.
-
Galli SJ, Galli AS, Dvorak AM, Dvorak HF. Metabolic studies of guinea pig basophilic leukocytes in short-term tissue culture. I. Measurement of histaminesynthesizing capacity by using an isotopic-thin layer chromatographic assay. J Immunol. 1976 Oct; 117(4):1085-92.
-
Colvin RB, Mihm MC, Dvorak HF. Letter: Cause of induration in skin tests (cont.). N Engl J Med. 1976 Sep 23; 295(13):734-5.
-
Orenstein NS, Hammond ME, Dvorak HF, Feder J. Esterase and protease activity of purified guinea pig basophil granules. Biochem Biophys Res Commun. 1976 Sep 7; 72(1):230-5.
-
Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol. 1976 Sep; 67(3):305-12.
-
Dvorak HF, Mihm MC, Dvorak AM. Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol. 1976 Sep; 67(3):391-401.
-
Dvorak HF. Cutaneous basophil hypersensitivity. J Allergy Clin Immunol. 1976 Jul; 58(1 PT. 2):229-40.
-
Soter NA, Mihm MC, Gigli I, Dvorak HF, Austen KF. Two distinct cellular patterns in cutaneous necrotizing angiitis. J Invest Dermatol. 1976 Jun; 66(6):344-50.
-
Dvorak AM, Dickersin GR, Connell A, Carey RW, Dvorak HF. Degranulation mechanisms in human leukemic basophils. Clin Immunol Immunopathol. 1976 Mar; 5(2):235-46.
-
Dvorak AM, Mihm MC, Dvorak HF. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol. 1976 Mar; 116(3):687-95.
-
Dvorak AM, Mihm MC, Dvorak HF. Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest. 1976 Feb; 34(2):179-91.
-
Colvin RB, Dvorak HF. Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena. J Exp Med. 1975 Dec 1; 142(6):1377-90.
-
Hammond ME, Selvaggio SS, Dvorak HF. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism. J Immunol. 1975 Oct; 115(4):914-21.
-
Dvorak HF, Dvorak AM. Basophilic leucocytes: structure, function and role in disease. Clin Haematol. 1975 Oct; 4(3):651-83.
-
Ward PA, Dvorak HF, Cohen S, Yoshida T, Data R, Selvaggio SS. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms. J Immunol. 1975 May; 114(5):1523-31.
-
Colvin RB, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975 Jan; 114(1 Pt 2):377-87.
-
Dvorak HF, Colvin RB, Churchill WH. Specificity of basophils and lymphocytes in cutaneous basophil hypersensitivity. J Immunol. 1975 Jan; 114(1 Pt 2):507-11.
-
Dvorak HF, Selvaggio SS, Dvorak AM, Colvin RB, Lean DB, Rypysc J. Purification of basophilic leukocytes from guinea pig blood and bone marrow. J Immunol. 1974 Dec; 113(6):1694-702.
-
Hammond ME, Roblin RO, Dvorak AM, Selvaggio SS, Black PH, Dvorak HF. MIF-like activity in simian virus 40-transformed 3T3 fibroblast cultures. Science. 1974 Sep 13; 185(4155):955-7.
-
Dvorak HF, Mihm MC, Dvorak AM, Johnson RA, Manseau EJ, Morgan E, Colvin RB. Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest. 1974 Aug; 31(2):111-30.
-
Swartz MN, Dvorak HF. 0bituary: Dr. Louis Dienes. J Infect Dis. 1974 Jul; 130(1):89-91.
-
Dvorak AM, Dvorak HF. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure. Immunology. 1974 Jul; 27(1):99-114.
-
Colvin RB, Dvorak AM, Dvorak HF. Mast cells in the cortical tubular epithelium and interstitium in human renal disease. Hum Pathol. 1974 May; 5(3):315-26.
-
Colvin RB, Dvorak HF. Letter: Basophils and mast cells in renal allograft rejection. Lancet. 1974 Feb 9; 1(7850):212-4.
-
Dvorak HF, Dvorak AM, Mihm MC. Proceedings: Morphologic studies in cellular hypersensitivity in guinea pigs and man. Monogr Allergy. 1974; 8(0):54-65.
-
Colvin RB, Johnson RA, Mihm MC, Dvorak HF. Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med. 1973 Sep 1; 138(3):686-98.
-
Goldman MA, Simpson BA, Dvorak HF. Histamine and basophils in delayed-type hypersensitivity reactions. J Immunol. 1973 Jun; 110(6):1511-7.
-
Colvin RB, Pinn VW, Simpson BA, Dvorak HF. Cutaneous basophil hypersensitivity. IV. The "late reaction": sequel to Jones-Mote type hypersensitivity. Comparison with rabbit Arthus reaction. Effect of passive antibody on induction and expression of Jones-Mote hypersensitivity. J Immunol. 1973 May; 110(5):1279-89.
-
Dvorak HF, Dvorak AM, Churchill WH. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates. J Exp Med. 1973 Mar 1; 137(3):751-75.
-
Dvorak HF, Dvorak AM. Basophilic leukocytes in delayed-type hypersensitivity reactions in experimental animals and man. Adv Exp Med Biol. 1973; 29(0):573-9.
-
Dvorak HF, Dvorak AM. Basophils, mast cells, and cellular immunity in animals and man. Hum Pathol. 1972 Dec; 3(4):454-6.
-
Dvorak AM, Hammond ME, Dvorak HF, Karnovsky MJ. Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes. Lab Invest. 1972 Dec; 27(6):561-74.
-
Hammond ME, Dvorak HF. Antigen-induced stimulation of glucosamine incorporation by guinea pig peritoneal macrophages in delayed hypersensitivity. J Exp Med. 1972 Dec 1; 136(6):1518-32.
-
Dvorak AM, Dvorak HF, Karnovsky MJ. Cytochemical localization of peroxidase activity in the developing erythrocyte. Am J Pathol. 1972 May; 67(2):303-26.
-
Dvorak HF, Mihm MC. Basophilic leukocytes in allergic contact dermatitis. J Exp Med. 1972 Feb 1; 135(2):235-54.
-
Dvorak AM, Dvorak HF, Karnovsky MJ. Uptake of horseradish peroxidase by guinea pig basophilic leukocytes. Lab Invest. 1972 Jan; 26(1):27-39.
-
Dvorak HF, Hirsch MS. Role of basophilic leukocytes in cellular immunity to vaccinia virus infection. J Immunol. 1971 Dec; 107(6):1576-82.
-
Dvorak AM, Bast RC, Dvorak HF. Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture. J Immunol. 1971 Aug; 107(2):422-35.
-
Dvorak HF, Mihm MC. Basophilic leukocytes in a case of poison ivy. N Engl J Med. 1971 Jul 1; 285(1):54-5.
-
Dvorak HF, Simpson BA, Bast RC, Leskowitz S. Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer. J Immunol. 1971 Jul; 107(1):138-48.
-
Bast RC, Simpson BA, Dvorak HF. Heterogeneity of the cellular immune response. II. The role of adjuvant, lymphocyte stimulation in cutaneous basophil hypersensitivity. J Exp Med. 1971 Feb 1; 133(2):202-15.
-
Bast RC, Manseau EJ, Dvorak HF. Heterogeneity of the cellular immune response. I. Kinetics of lymphocyte stimulation during sensitization and recovery from tolerance. J Exp Med. 1971 Feb 1; 133(2):187-201.
-
Dvorak HF. Role of the basophilic leukocyte in allograft rejection. J Immunol. 1971 Jan; 106(1):279-81.
-
Dvorak HF, Wetzel BK, Heppel LA. Biochemical and cytochemical evidence for the polar concentration of periplasmic enzymes in a "minicell" strain of Escherichia coli. J Bacteriol. 1970 Oct; 104(1):543-8.
-
Wetzel BK, Spicer SS, Dvorak HF, Heppel LA. Cytochemical localization of certain phosphatases in Escherichia coli. J Bacteriol. 1970 Oct; 104(1):529-42.
-
Richerson HB, Dvorak HF, Leskowitz S. Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J Exp Med. 1970 Sep 1; 132(3):546-57.
-
Dvorak HF, Dvorak AM, Simpson BA, Richerson HB, Leskowitz S, Karnovsky MJ. Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med. 1970 Sep 1; 132(3):558-82.
-
Dvorak HF, Simpson BA, Flax MH, Leskowitz S. The fate of antigen in delayed hypersensitivity skin reactions. J Immunol. 1970 Mar; 104(3):718-27.
-
Dvorak HF, Bast RC. Nature of the immunogen in crystalline serum albumins. Immunochemistry. 1970 Jan; 7(1):118-24.
-
Richerson HB, Dvorak HF, Leskowitz S. Cutaneous basophilic hypersensitivity: a new interpretation of the Jones-Mote reaction. J Immunol. 1969 Dec; 103(6):1431-4.
-
Dvorak HF. Disseminated intravascular coagulation. N Engl J Med. 1969 Aug 7; 281(6):329.
-
Dvorak HF, Simpson BA, Bast RC. Immunologic unresponsiveness in the adult guinea pig. IV. Induction of unresponsiveness with aggregated serum proteins. J Immunol. 1969 May; 102(5):1163-71.
-
Dvorak HF. Metallo-enzymes released from Escherichia coli by osmotic shock. I. Selective depression of enzymes in cells grown in the presence of ethylenediaminetetraacetate. J Biol Chem. 1968 May 25; 243(10):2640-6.
-
Dvorak HF, Heppel LA. Metallo-enzymes released from Escherichia coli by osmotic shock. II. Evidence that 5'-nucleotidase and cyclic phosphodiesterase are zinc metallo-enzymes. J Biol Chem. 1968 May 25; 243(10):2647-53.
-
Dvorak HF, Brockman RW, Heppel LA. Purification and properties of two acid phosphatase fractions isolated from osmotic shock fluid of Escherichia coli. Biochemistry. 1967 Jun; 6(6):1743-51.
-
Dvorak HF, Anraku Y, Heppel LA. The occurrence of a protein inhibitor for 5'-nucleotidase in extracts of Escherichia coli. Biochem Biophys Res Commun. 1966 Sep 8; 24(5):628-32.
-
Dvorak HF, Billote JB, McCarthy JS, Flax MH. Immunologic unresponsiveness in the adult guinea pig. 3. Variation of the antigen and vehicle of suppression. Induction of unresponsiveness in the adult rat. J Immunol. 1966 Jul; 97(1):106-11.
-
Dvorak HF, Flax MH. Immunologic unresponsiveness in the adult guinea pig. II. The kinetics of unresponsiveness. J Immunol. 1966 Mar; 96(3):546-53.
-
Dvorak HF, Cohen RB. Localization of skeletal muscle phosphorylase using a fluorescent antibody technique and its correlation with histochemical observations. J Histochem Cytochem. 1965 Jul-Aug; 13(6):454-60.
-
DVORAK HF, BILLOTE JB, MCCARTHY JS, FLAX MH. IMMUNOLOGIC UNRESPONSIVENESS IN THE ADULT GUINEA PIG. I. SUPPRESSION OF DELAYED HYPERSENSITIVITY AND ANTIBODY FORMATION TO PROTEIN ANTIGENS. J Immunol. 1965 Jun; 94:966-75.
-
HULLEY SB, DVORAK HF, WAKSMAN BH. EFFECT OF MACROPHAGES ON PRIMARY IMMUNIZATION OF LYMPH NODE CELLS AGAINST HOMOGRAFTS IN DIFFUSION CHAMBERS. Proc Soc Exp Biol Med. 1964 Oct; 117:110-5.
-
KOSUNEN TU, DVORAK HF. The "transfer reaction" in the rabbit. II. A radioautographic study. Lab Invest. 1963 Jun; 12:628-37.
-
JANKOVIC BD, DVORAK HF. Enzymatic inactivation of immunologically competent lyph node cells in the "transfer reaction". J Immunol. 1962 Oct; 89:571-81.
-
DVORAK HF, WAKSMAN BH. Primary immunization of lymph node cells in millipore chambers by exposure to homograft antigen. J Exp Med. 1962 Jul 1; 116:1-16.
-
JANKOVIC BD, DVORAK HF. Effect of ribonuclease upon immunologically active cells. Proc Soc Exp Biol Med. 1961 Dec; 108:564-6.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Dvorak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|